secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2026-09-08T20:05:26+00:00
Accession:  0001104659-26-105901
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents completes 1-for-20 reverse stock split effective Sept 8, 2026
--------------------------------------------------------------------------

- Reverse split effective 12:01 a.m. ET Sept 8, 2026; approved by shareholders at Aug 13, 2026 annual meeting.
- Pre-split shares outstanding: 63,022,020; every 20 shares reclassified to 1 share, par value unchanged.
- No fractional shares; fractional entitlements rounded up to nearest whole share; Equiniti Trust is exchange agent.
- Outstanding options and warrants proportionally adjusted with corresponding exercise price changes.
- New CUSIP 23283X305; trading on Nasdaq continues on split-adjusted basis from Sept 8, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465926105901/0001104659-26-105901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465926105901/tm2624941d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-105901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer